Munich, Georgia

Jørgen Skov Jensen


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Jørgen Skov Jensen: Innovating In Vitro Fertilization

Introduction

Jørgen Skov Jensen, a forward-thinking inventor based in Søborg, Denmark, has made significant contributions to the field of reproductive medicine. With one patent to his name, he has developed an innovative method aimed at improving the success rates of in vitro fertilization (IVF) for women facing challenges related to abnormal vaginal microbiota.

Latest Patents

Jensen's patent, titled "Use of Vaginal for Improving the Success Rate of In Vitro Fertilization," introduces a novel approach to enhance IVF outcomes. This invention entails a comprehensive method that includes selecting women suspected of hosting abnormal vaginal microbiota, administering a suitable antibiotic to reduce these irregularities, and then introducing beneficial species via vaginal administration. The final step involves transferring an embryo into the woman, thereby improving her chances of conception.

Career Highlights

Currently, Jørgen Skov Jensen is associated with Osel, Inc., where he collaborates with fellow innovators in the field. His expertise in reproductive health and microbiota has positioned him as a key contributor to advancements in IVF technology.

Collaborations

Throughout his career, Jensen has worked alongside accomplished professionals such as Thomas P Parks and Peter Humaidan. Their collective efforts have driven research and development in reproductive technologies, providing valuable insights and fostering innovation.

Conclusion

Jørgen Skov Jensen stands as a prominent figure in the realm of reproductive medicine, demonstrating how targeted innovations can significantly impact the success of in vitro fertilization. His patent not only highlights his inventive spirit but also underscores the critical intersection of microbiology and reproductive health in advancing fertility treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…